BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16208675)

  • 1. Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis.
    Dominick KL; Dudley TK; Coffman CJ; Bosworth HB
    Arthritis Rheum; 2005 Oct; 53(5):666-72. PubMed ID: 16208675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of comorbidity measurements to predict healthcare expenditures.
    Farley JF; Harley CR; Devine JW
    Am J Manag Care; 2006 Feb; 12(2):110-9. PubMed ID: 16464140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke: the Elixhauser Index for comorbidity adjustment of in-hospital case fatality.
    Zhu H; Hill MD
    Neurology; 2008 Jul; 71(4):283-7. PubMed ID: 18645167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting costs of care using a pharmacy-based measure risk adjustment in a veteran population.
    Sales AE; Liu CF; Sloan KL; Malkin J; Fishman PA; Rosen AK; Loveland S; Paul Nichol W; Suzuki NT; Perrin E; Sharp ND; Todd-Stenberg J
    Med Care; 2003 Jun; 41(6):753-60. PubMed ID: 12773841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases.
    Li B; Evans D; Faris P; Dean S; Quan H
    BMC Health Serv Res; 2008 Jan; 8():12. PubMed ID: 18194561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data.
    van Walraven C; Austin PC; Jennings A; Quan H; Forster AJ
    Med Care; 2009 Jun; 47(6):626-33. PubMed ID: 19433995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of medication-based co-morbidity indices in the Australian elderly population.
    Vitry A; Wong SA; Roughead EE; Ramsay E; Barratt J
    Aust N Z J Public Health; 2009 Apr; 33(2):126-30. PubMed ID: 19413854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery.
    Nuttall M; van der Meulen J; Emberton M
    J Clin Epidemiol; 2006 Mar; 59(3):265-73. PubMed ID: 16488357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative study on comorbidity measurements with Lookback period using health insurance database: focused on patients who underwent percutaneous coronary intervention].
    Kim KH; Ahn LS
    J Prev Med Public Health; 2009 Jul; 42(4):267-73. PubMed ID: 19675404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a pharmacy-based comorbidity measure in a population-based automated health care database.
    Dong YH; Chang CH; Shau WY; Kuo RN; Lai MS; Chan KA
    Pharmacotherapy; 2013 Feb; 33(2):126-36. PubMed ID: 23386595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidity scores for administrative data benefited from adaptation to local coding and diagnostic practices.
    Bottle A; Aylin P
    J Clin Epidemiol; 2011 Dec; 64(12):1426-33. PubMed ID: 21764557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating osteoarthritis incidence from population-based administrative health care databases.
    Sun J; Gooch K; Svenson LW; Bell NR; Frank C
    Ann Epidemiol; 2007 Jan; 17(1):51-6. PubMed ID: 17027284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting healthcare utilization using a pharmacy-based metric with the WHO's Anatomic Therapeutic Chemical algorithm.
    Kuo RN; Dong YH; Liu JP; Chang CH; Shau WY; Lai MS
    Med Care; 2011 Nov; 49(11):1031-9. PubMed ID: 21945973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Databases for assessing the outcomes of the treatment of patients with congenital and paediatric cardiac disease--the perspective of critical care.
    LaRovere JM; Jeffries HE; Sachdeva RC; Rice TB; Wetzel RC; Cooper DS; Bird GL; Ghanayem NS; Checchia PA; Chang AC; Wessel DL
    Cardiol Young; 2008 Dec; 18 Suppl 2():130-6. PubMed ID: 19063783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing co-morbidities in total joint arthroplasty patients using the RxRisk-V, Elixhauser, and Charlson Measures: a cross-sectional evaluation.
    Inacio MC; Pratt NL; Roughead EE; Graves SE
    BMC Musculoskelet Disord; 2015 Dec; 16():385. PubMed ID: 26652166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepines and injury: a risk adjusted model.
    French DD; Campbell R; Spehar A; Angaran DM
    Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):17-24. PubMed ID: 15386711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the performance of the CMS Hierarchical Condition Category (CMS-HCC) risk adjuster with the Charlson and Elixhauser comorbidity measures in predicting mortality.
    Li P; Kim MM; Doshi JA
    BMC Health Serv Res; 2010 Aug; 10():245. PubMed ID: 20727154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient medical and mental healthcare utilization models among military veterans: results from the 2001 National Survey of Veterans.
    Elhai JD; Grubaugh AL; Richardson JD; Egede LE; Creamer M
    J Psychiatr Res; 2008 Aug; 42(10):858-67. PubMed ID: 18005993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shaping health workforce policy through data-driven analyses: the North Carolina health professions data system.
    King J; Holmes M
    N C Med J; 2008; 69(2):139-41. PubMed ID: 18605165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.